Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI , KD News,

Gennova Biopharmaceuticals has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity.

Posted from: 0001-01-01 00:00:00Z2022-03-18 17:41:03Z[]this blog via Microsoft Power Automate.